19 funding opportunities are listed in this category
Multiple Sclerosis Center Quality of Life Grants
Since 1996, the Multiple Sclerosis Foundation (MSF) has awarded grants and endowments to universities, MS centers, and other nonprofit organizations to actively promote quality of life and create a brighter tomorrow for those living with MS. MS centers and nonprofit organizations, with a physical presence in the United States, in need of expanding their programs and services are also eligible for financial assistance from the MSF. Grants are available for implementing or expanding MS Day Programs, diagnostic services, rehabilitation services, support services, social services, education and outreach, and medical care.Applications are accepted beginning September 1st of each year. Applications must be postmarked between September 1st and November 1st to be eligible for funding.
Eligibility:• New and existing centers with a physical presence in the United States.• Centers serving twenty-five or more MS patients.
Priority will be given to efforts that:• Address unmet needs• Enhance or expand current services• Use creative and innovative approaches to achieve positive outcomes• Fill gaps in current services
Areas not funded:• Grants for research• Grants to individuals• Grants for religious purposes• Grants for items covered under existing MSF programs
Size and types of grants:• Funding decisions will be based on the type and scope of the program. Due to the wide variety of program designs expected, varying amounts of funding will be provided. Generally, the MSF funds programs in the range of $5,000 to $40,000.For further information on the MS Center Quality of Life grant, call Alan Segaloff, Executive Director at 1-800-225-6495.
Multiple Sclerosis Foundation6350 North Andrews AvenueFort Lauderdale, Florida 33309-2130
Multiple Sclerosis Foundation Grant Program
The initial contact should be made by letter of inquiry stating the amount sought, purpose of the grant, and nature of the organization requesting the grant. Please include an e-mail address if available. The letter should be sent to: The Grant Committee c/o Managing Director Multiple Sclerosis Foundation 6350 North Andrews Avenue Ft. Lauderdale, Fl. 33309If you are awarded a grant we do ask as a minimum that you provide us with semi-annual progress reports however additional criteria may apply depending on the amount and type of grant.FUNDING CYCLEAll grant requests, excluding the Brighter Tomorrow grant, must be postmrked between September 1 and November 1 of each year. If your request is funded, funding will occur prior to January 15 of the following year.LIMITATIONS AND EXCLUSIONSThe Multiple Sclerosis Foundation, at its sole discretion, has the right to limit, refuse or cancel any grants made. The awarding of grants is at the determination of the Multiple Sclerosis Foundation.
Multiple Sclerosis Foundation Computer Grant Program
Computer Grant Program provides refurbished laptop or desktop computers for individuals with MS on limited or fixed incomes. For those who do not know how to use a computer, training may be provided. The application process requires verification of a diagnosis of MS and a brief essay from the applicant explaining how a computer will enhance their quality of life. A computer, monitor, keyboard and mouse will be granted. Internet access and technical support will be the responsibility of the grant recipient. Applications are accepted from July 1 to October 1 of each year.
Multiple Sclerosis Foundation Brighter Tomorrow Grant
Each year the Multiple Sclerosis Foundation makes dreams come true for individuals with multiple sclerosis across the country through the Brighter Tomorrow grant.The goal of the grant is provide individuals with MS with goods or services (valued at up to $1000.00 per recipient) to improve their quality of life by enhancing safety, self-sufficiency, comfort, or well-being.Recipients of the Multiple Sclerosis Foundation's Brighter Tomorrow grant have received car repairs, ramps, wheelchairs, walkers, eyeglasses, computers, appliances, televisions, furniture, therapeutic equipment, hobby supplies, retreats, and various home modifications.To qualify, a person must be 18 years of age or older and diagnosed with MS, or the parent of a minor child diagnosed with MS, and be a permanent U.S. resident. They must not have any other means of fulfilling the need they express.Applicants are asked to provide basic personal and financial information, and to write a brief essay of 100 words or less to describe how the grant would help them have A Brighter Tomorrow.If you would like to apply for a Brighter Tomorrow grant, simply fill out our online application, print an application, or call 888-673-6287 to receive an application by mail. Applications are accepted from July 1 to October 1 of each year.For further information on the Brighter Tomorrow grant, call our Program Services Department at 1-888-MSFOCUS or you can contact us by email: support@msfocus.org.- Partially funded through a charitable donation from the Bayer Foundation.Official GuidelinesApplications submitted must fulfill the following eligibility criteria to be considered for funding: * Applicant must be diagnosed with MS, or be the parent of a minor child with MS. * Applicant must be over the age of 18. * Applicant must have no existing financial net (such as Medicaid or private insurance) to cover the request. * Applicant must grant the MSF the right to use their name and photograph for promotional purposes. * Applicant must agree to sign a disclaimer. * Applicant must be a resident of the United States. * Request must be for specific goods or services. * Cash, medications, or items available through current programs are not included.
Spina Bifida Association/Spina Bifida Foundation Young Investigator Awards 2010 Request for Proposals
Deadline: 9:00 pm eastern daylight time on Monday, May 10, 2010
The Spina Bifida Association (SBA) and the Spina Bifida Foundation (SBF) are pleased to announce a Request for Proposals to support basic or clinical Spina Bifida research by promising young investigators. SBA will award up to three (3) fellowships in 2010. The purpose of the awards will be to provide either initial or continuing financial support to a newly-independent investigator in an established research program. One fellowship, providing up to $50,000 in support, is named the Ashley Rose Advancement in Research Award. The Ashley Rose Foundation was established by Raymond and Linda Pitek in 1997 for their baby, Ashley Rose. Another fellowship will offer $25,000 and was established in 2008 by the Schneider Charitable Trust, established by Hollister Incorporated. Up to $40,000 is available for a third fellowship, in its second year, for research relating to tethered cord syndrome. EligibilityThe investigator must be a citizen of the United States of America and possess an MD, PhD, DSW, DScN, or equivalent terminal degree prior to beginning the research under the award, but may not have held a faculty title of Assistant Professor (or equivalent) or higher for more than 24 months at the time the fellowship is to begin. The individual may be contemplating a fellowship or may already have begun one, but must be conducting the proposed research in preparation for a research or research and clinical career. The research program in which the fellow is to be appointed must be located in the United States of America and may be at an academic medical institution, hospital, research institute, university, or similar institution. It must be sufficiently established to provide strong support for the fellow, but need not have involved Spina Bifida research previously. The research to be conducted by the fellow may be basic or clinical research, but must be relevant to Spina Bifida. Areas of particular interest are:•Ashley Rose Research Advancement Award – Epidemiology and causes of miscarriage related to neural tube defects preferred; other related research will be considered•Schneider Charitable Trust Research Fellowship – Continence and related clinical and scientific areas•Tethered Cord Syndrome Research Fellowship – Tethered Cord Syndrome and related clinical and scientific areasAward MechanismThe institution at which the established research program is located will be the awardee and will be expected to administer the award on behalf of the faculty or fellow, who will be the principal investigator. The award mechanism will be a grant, payable in a single installment within 30 days following written acceptance of the grant by the institution and the fellow. The grant will begin at the awardee institution’s discretion between August 1 and December 1, 2010, and will be for a one-year period unless prior written approval for a no-cost extension is requested by the institution and approved by SBA.Criteria for SelectionA committee of scientists, clinicians familiar with Spina Bifida research and those affected by Spina Bifida will conduct a peer review of all eligible proposals received. Based on recommendations of the peer review committee, awards will be made by SBA. The peer review committee will consider all of the following criteria in making its recommendations:•Strength of the science of the research proposal•Educational preparation and demonstrated potential for research of the fellow •Degree of intellectual and resource support committed by the established research program hosting the fellow apparent long-term interest in Spina Bifida expressed by the fellowSBA does not anticipate issuing comments on individual proposals by the peer review committee.
Spina Bifida Association4590 MacArthur Boulevard, NW Suite 250Washington , DC 20007Phone: 202-944-3285Toll Free: 800-621-3141Fax: 202-944-3295General inquiries: sbaa@sbaa.org
Friedreich's Ataxia Research Alliance New Investigator Grants
These grant awards are for young or new investigators who have demonstrated an interest in FA research and want to further that commitment. We believe in welcoming, mentoring and supporting new scientists in the FA research community so that they have the necessary experience and motivation to launch successful independent careers. Guidelines for New Investigator Grants New Investigator Grants are accepted twice a year March 1st and September 1st then awards are announced June 1st and December 1st. The terms of the awards are July 1 – June 30 for awards submitted March 1st and January 1 – December 31 for awards submitted September 1st. Grant proposals should not exceed 24 months in duration. Grant awards are made in one year allocations. All subsequent payments are contingent upon receipt and satisfactory review of a progress report. FARA reserves the right terminate any grant award for inadequate progress, failure to submit reports, deviation in scope of the original research, and/or changes in funding priority. All grants should be submitted using FARA’s Research Portfolio Management Program – www.curefa.org/rpmp On the Main Grant Page of the application please indicate “NIA” in the RFP field. A letter of support should be provided by the applicant’s supervisor/advisor. A personal statement from the applicant should also be included that addresses the applicant’s current interests, career goals and interest in Friedreich’s ataxia research. FARA only funds direct costs. No indirect costs will be awarded. A detailed budget must be submitted with all proposals, including a justification to support reported expenses. Reasonable and customary salary support and benefits are acceptable for the applicant. The budget should not exceed $100,000. Additional allowable expenses include: laboratory reagents and supplies, equipment, animal expenses, patient expenses directly related to study and not reimbursable by third party insurers, patient travel Expenses not awarded: indirect costs/overhead, travel to meetings and conferences, membership to scientific societies Individuals who receive this award cannot reapply through this same mechanism. This award is intended to help the scientist achieve additional sources of funding and independence. If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB). Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied in the course of research conducted under a grant are under no circumstances a responsibility of FARA. If animals are used in the proposed study, the study must be approved by the Institutional Animal Care and Use Committee (or equivalent) indicating that appropriate precautions have been taken to assure that proper treatment, care and humane conditions have been provided.
Friedreich's Ataxia Research Alliance 102 Pickering Way, Suite 200 Exton, PA 19341 USA Phone: (484) 875-3015 Fax: (610) 363-1506 Email: info@cureFA.org Website: www.cureFA.org
CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects
Grant submission deadline is April 1, 2010 Two, CBD-related grants are available for up to $75,000 for a period of one to two years
VISION Cure and prevent PSP and CBD
MISSION STATEMENT Increase awareness of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), fund research toward a cure and prevention, educate health professionals, and provide support, information and hope for persons and families with PSP and CBD.
The Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports and promotes research that can advance the understanding and treatment of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
INVESTIGATOR-INITIATED RESEARCH CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular, cellular, and clinical levels.
CurePSP is particularly interested in research that will help us: 1. Understand the role of the tau gene and other genes in PSP and CBD. 2. Understand the role of tau protein processing in PSP and CBD. 3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD. 4. Understand environmental factors that influence the development or course of PSP and CBD. 5. Understand the series of changes brain cells pass through in PSP and CBD as they progress from healthy neurons to dysfunctional neurons. 6. Characterize the natural history of PSP and CBD in order to develop outcome measures for clinical trials. 7. Develop animal models of PSP and CBD. 8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessment of treatment. 9. Develop treatments that improve the symptoms of persons with PSP and CBD. 10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.
CurePSP Executive Plaza III 11350 McCormick Road, Suite 906 Hunt Valley, MD 21031 Phone: 800-457-4777 E-mail: info@curepsp.org Website: www.curepsp.org
Cure Congenital Muscular Dystrophy Research Grants
Cure CMD Research Grant GoalsCure CMD research goals reflect our mission to bring research, treatments and in the future, a cure for the congenital muscular dystrophies. 1. Identify new therapeutic targets in the CMDs 2. Identify small molecule compounds that work at these therapeutic target sites with priority towards drugs with existing pediatric FDA approval 3. Facilitate the drug development process to ensure that each positive drug identification with promising preliminary data can be brought rapidly to preclinical trials and subsequent treatment trials 4. Support and endorse clinical research, infrastructure and biomarker discovery required to launch effective and efficient clinical trials in rare disease 5. Advance drug discovery with a diverse treatment pipeline 6. Support new scientific investigators with innovative ideas and a commitment to CMD researchStruggle Against Muscular Dystrophy (S.A.M) CMD Translational Research Grant: Annual Deadline, Sept 15th.
S.A.M is a unique CMD advocacy group launched by two parents whose son has CMD. SAM’s focus is to support and foster CMD research through successful fundraising initiatives. The SAM Translational Research Award delivers upon its promise to target research focused on CMD treatment. The grant is made possible through Cure CMD and SAM collaboration and the Cure CMD research grant funding mechanism.Cure CMD and SAM invite proposals to award a 1-2 year grant focusing on pre-clinical and clinical investigations that will advance treatment for congenital muscular dystrophy (CMD). The total award is limited to $100,000 (direct costs only). Annual RFA deadline Sept 15th. Grant application above. On the First Page of the Cure CMD grant application, please specify S.A.M. CMD Translational Research Grant
Cure CMD General Research Grants: Annual Deadline Sept 15th.
Elisabeth Giauque Short Term CMD Research Grant: Cure CMD provides a short-range or “seed” grant (usually $25,000- $50,000 per year for 1-2 years, direct costs only) to attract new investigators to the CMD field and assist existing investigators to support early phases of their research. The short-range grant focus is to collect preliminary data and test initial hypotheses. The short-range grant goal is to translate successful preliminary research to either second tier Cure CMD midrange grants (R-21 type) or third tier, long range (R-01 grants, 2-5 years) from outside funding sources, such as the National Institutes of Health. Annual RFA deadline, Sept 15th. Grant application above. On the first page of the Cure CMD grant application, please specify Elisabeth Giauque Short Term CMD Research Grant.
info@curecmd.comCure CMDP.O. Box 701Olathe, KS 66051Ph. 1-866-400-3626
Benign Essential Blepharospasm Research Foundation, Inc. Request for Research Grant Proposals
Deadline for Submitting Request: August 31, 2010
* Funds up to $150,000 are available for support of research directly related to blepharospasm or Meige's Syndrome, both forms of cranial dystonia * M.D. or Ph.D. required for principal investigator * Non-U.S. citizens, working at institutions abroad are also eligible to apply for a research grant * Research proposals must relate specifically to benign essential blepharospasm and Meige to include new treatments, pathophysiology and genetics, photophobia and dry eye. * If a grant is awarded, we expect a semiannual progress report * Deadline to apply is August 31 each year. Benign Essential Blepharospasm Research Foundation, Inc. P.O. Box 12468 Beaumont, TX 77726-2468 Tel: (409) 832-0788 Fax: (409) 832-0890 E-mail: bebrf@blepharospasm.org
Batten Disease Support and Research Association 2010 Request for Proposals
THe 2010 Request for Proposal is now available. Submitted proposals must be postmarked no later than 11:59PM , May 15, 2010. Emailed proposals will NOT be accepted. Inquiries may be directed to Lance W. Johnston, Executive Director, BDSRA, at 1-800-448-4570 or 740-927-4298. Email address: bdsra1@bdsra.org.
The Batten Disease Support and Research Association (BDSRA) is pleased to announce that limited funds are available to promote research and/or assist in a viable research project/s primarily for, but not limited to, development of novel therapeutic approaches to treatment for Neuronal Ceroid Lipofuscinosis, including the identification of bioactive compounds and characterization of cell-based therapeutic strategies, neuroimaging, proteomic and genomic approaches, and development of treatments that will alleviate the symptoms of Batten Disease. Also approaches exploring the neurobiology of NCL disease and determining the molecular pathogenesis in the CNS and further understanding the cell biology of the NCL proteins/enzymes. Proposals will be received for all forms of NCL with emphasis on CLN1, CLN2, and CLN3. Multiyear proposals are generally discouraged unless there are extenuating circumstances or the study/project requires it.BDSRA is including in its 2010 Request for Proposals, the establishment of a new postdoctoral fellowship. Proposals must include the percentage of time the candidate will expend on the project. Proposal must also include letter from established scientist or lab in which the posdtdoc will be working acknowledging the applicants position. Note: Funding for second and/or third year will be predicated on review of previous work and likelihood of achieving goals. Funding will not accompany if individual changes institution or lab unless preauthorized by BDSRA.All grant award(s) must be used to cover direct costs of the project/ investigation and may not be used for indirect or overhead costs. All awards, including Postdoctoral fellowship, will be paid in six (6) month increments based on report submitted for review. In the event of any changes, such changes will be announced on the BDSRA website - http://www.bdsra.org.
Batten Disease Support and Research Association166 Humphries Dr.Reynoldsburg, OH 43068
12next
